L859-0224 Screening compound: 2-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-cyclohexylacetamide

L859-0224 Screening compound: 2-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-cyclohexylacetamide
L859-0224 Screening compound: 2-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-cyclohexylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L859-0224
2-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-cyclohexylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L859-0224

Molecular Formula

C25H24ClN5O3 (C25 H24 ClN5 O3)

Compound Name

2-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-cyclohexylacetamide

IUPAC name

2-{3-[3-(4-chlorophenyl)-124-oxadiazol-5-yl]-7-methyl-4-oxo-14-dihydro-18-naphthyridin-1-yl}-N-cyclohexylacetamide

SMILES

Cc(cc1)nc(N(CC(NC2CCCCC2)=O)C=C2c3nc(-c(cc4)ccc4Cl)no3)c1C2=O

InChI

InChI=1S/C25H24ClN5O3/c1-15-7-12-19-22(33)20(25-29-23(30-34-25)16-8-10-17(26)11-9-16)13-31(24(19)27-15)14-21(32)28-18-5-3-2-4-6-18/h7-13,18H,2-6,14H2,1H3,(H,28,32)

InChI Key

PJNFRLRHJYAFPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27481279

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.95

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.547

Distribution Coefficient, logD

5.547

Water Solubility, LogSw

-5.81

Polar Surface Area

80.870

Acid Dissociation Constant (pKa)

15.76

Base Dissociation Constant (pKb)

1.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

L859-0224 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L859-0224 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L859-0224?
Check Price and Availability of L859-0224, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L859-0224 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L859-0224
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L859-0224
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L859-0224 available by request